Israel, Korea to fund more R&D

The Korea-Israel Industrial R&D Foundation announced on Monday that they have granted $1.5m. in funding for five projects to be undertaken by teams of Israeli and Korean technology companies.

By MATTHEW KRIEGER
November 27, 2007 08:16

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Korea-Israel Industrial R&D Foundation announced on Monday that they have granted $1.5 million in funding for five projects to be undertaken by teams of Israeli and Korean technology companies. KORIL was established in May 2001, initiated by a treaty between the Israeli and Korean governments. The treaty was ratified for the purpose of promoting joint industrial R&D collaborations between companies in Korea and Israel that have potential to develop commercial projects or processes.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS